Investor calls out excess CEO pay at $DOC
Investor Jonathan Litt publicly criticized excessive CEO compensation at $DOC and urged votes against the compensation committee ahead of the April 30 annual meeting — citing shareholder returns lagging peers by roughly 16% to 67%. The call adds pressure on comp committees facing activist scrutiny. (x.com)
Healthpeak Properties — which began trading under the DOC ticker after merging with Physicians Realty Trust on March 4, 2024 — has a virtual annual meeting set for April 30, 2026 where shareholders will be asked to elect nine directors and cast an advisory vote on 2025 executive compensation. (ir.healthpeak.com) Scott M. Brinker’s total 2025 compensation has been reported at about $10.07 million, an increase of roughly 16% from an estimated $8.47 million in 2024. (quiverquant.com) Proxy summaries and company disclosures show Brinker’s package is heavily equity‑and performance‑based, with base salary comprising around 8% of total reported pay and long‑term incentive units disclosed in the company’s filings. (simplywall.st) Healthpeak’s definitive proxy states the Compensation and Human Capital Committee will review and consider the outcome of the advisory say‑on‑pay vote when making future compensation decisions for named executive officers. (sec.gov) Land & Buildings has previously published a white paper and repeatedly pressed REIT boards on pay practice issues, arguing boards sometimes build peer groups to justify larger CEO awards and mounting vote‑no pressure on compensation committees. (landandbuildings.com) Institutional proxy advisers updated their 2026 pay‑for‑performance models ahead of this season — Glass Lewis and ISS rolled out revised methodologies that will factor into say‑on‑pay recommendations for meetings on or after February 1, 2026, increasing the weight of quantitative P4P results in voting guidance. (glasslewis.com)
